More PRNewswire
View Older Stories View Newer Stories-
Locus FS Demonstrates Mid-Year Growth Momentum as Demand Accelerates for Bio-Based Additives Across Industrial Markets
-
'All Rise' for Edinburgh International Festival 2026
-
WebPT Names Dr. Alex Bendersky Head of Clinical Innovation
-
Edgewise Therapeutics Reports Second Quarter 2026 Financial Results
-
Stand Up To Cancer Announces Winner of Maverick Early Career Scientist Award
-
ONCOR REPORTS SECOND QUARTER 2026 RESULTS
-
Aspen Dental Opens Its First Shelby County Practice in Alabaster's District 31 Development
-
Silver Arch Capital Partners Provides $5,660,000 Loan for Mixed-Use Multifamily Development in Huntington Station, NY
-
IQST - IQSTEL Expects to Surpass an $8 Million Adjusted EBITDA Run Rate This Quarter as It Leverages Its Global Platform to Accelerate Growth
-
Sempra Reports Strong Second-Quarter 2026 Results
-
KOPPERS REPORTS SECOND QUARTER 2026 RESULTS
-
Sabre's second quarter 2026 earnings materials available on its Investor Relations website
-
Xonar Technology Achieves SOC 2 Type II Examination
-
NetEase Cloud Music Inc. to Report First Half 2026 Financial Results on August 20, 2026
-
UK COMPETITION AND MARKETS AUTHORITY APPROVES PARAMOUNT SKYDANCE CORPORATION ACQUISITION OF WARNER BROS. DISCOVERY
-
Nuvation Bio Reports Second Quarter 2026 Financial Results and Provides Business Update
-
F&G Annuities & Life Declares Dividends on Common and Preferred Stock
-
Fidelity National Financial Announces Quarterly Cash Dividend of $0.52
-
Nova Reports Record Second Quarter 2026 Financial Results
-
CME Group Declares Quarterly Dividend
-
Cars.com Reports Second Quarter 2026 Results
-
Suburban Propane Partners, L.P. Announces Third Quarter Results
-
Payoneer Reports Second Quarter 2026 Financial Results
-
Heartland Dental CEO Pat Bauer Receives 2026 Dental Titan Award for Leadership and Lasting Impact on Doctor-Led Dentistry
-
Ractigen Therapeutics Announces Completion of Enrollment and First Dosing in Phase II Clinical Trial of RAG-17 for SOD1-ALS
-
ATI Announces Second Quarter 2026 Results
-
ADC Therapeutics to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026
-
Mohegan Invites You to Join Its Third Quarter Fiscal 2026 Operating Results Conference Call
-
SUNSTONE HOTEL INVESTORS REPORTS RESULTS FOR SECOND QUARTER 2026
-
Charter Announces Results Of Early Tenders In Debt Exchange Offers And Amendment And Upsize of Debt Exchange Offers
-
LUX Infusion Acquires Infuse IQ, Expanding Its National Ambulatory Infusion Footprint
-
Natural Grocers® Celebrates Missouri Day with a Special Gift and Savings August 10-12, 2026
-
Hydreight to Participate in Canaccord Genuity's 46th Annual Growth Conference in Boston
-
Verified Clinical Trials Partners with WindRose Health Investors to Accelerate Growth and Welcomes Howard Miller as Chief Executive Officer
-
REGENXBIO Reports Second Quarter 2026 Financial Results and Operational Highlights
-
Tripadvisor, Inc. Earnings Press Release Available on Company's Investor Relations Site
-
Arbe Appoints Assaf Pereg, CPA, as Chief Financial Officer
-
Australia's Department of Foreign Affairs and Trade Extends Partnership with Cambridge Global Advisors to Build Cyber Capacity Among Women in the Pacific
-
Bausch Health CEO Thomas J. Appio Joins Bausch + Lomb Board
-
Federal Realty Announces Proposed Private Placement of $400 Million of Exchangeable Senior Notes
-
Insmed Reports Second-Quarter 2026 Financial Results and Provides Business Update
-
Axcelis Announces Financial Results for Second Quarter 2026
-
Sharon AI Reports Second Quarter 2026 Results
-
Warner Bros. Discovery Reports Second Quarter 2026 Results
-
Keurig Dr Pepper Reports Q2 Results and Reaffirms Guidance for 2026
-
Mediar Therapeutics Enters into a Collaboration and Option Agreement with Ono Pharma to Develop Novel Treatments for Fibro-inflammatory Diseases
-
National Math Talent Fund Launches to Close America's Math Graduation Gap for 10,000 College Students
-
Run AI Where It Matters--At the Edge
-
As AI-Agent Liability Lands on Deployers, Bodaty's Open Source AICtrlNet Puts a Named Human on Every Consequential AI Action
-
Evolent Announces Second Quarter 2026 Results
